Skip to main content
. 2020 Nov 21;12(1):13–20. doi: 10.1111/1759-7714.13616

Table 3.

Estimates of average (and confidence interval) per‐patient costs of care for NSCLC by disease stage (€) during the first year after diagnosis

Average total costs Cost ratio vs. stage I
Stage I 16 291 (95% CI: 15 284–17 505) 1
Stage II 19 530 (95% CI: 18 263–21 091) 1.19
Stage III 21 938 (95% CI: 20 271–25 252) 1.34
Stage IV 22 175 (95% CI: 22 127–22 190) 1.36
Pancoast 28 711 (95% CI: 27 711–29 890) 1.79
TOTAL 21 328 (95% CI: ‐20 897–22 322)